🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for HealthTech

Benchmark revenue and EBITDA valuation multiples for public comps like DexCom, Stryker, UnitedHealth Group, Siemens and Boston Scientific.

HealthTech

See analyst estimates and all valuation multiples for HealthTech
Company EV EV/Revenue EV/EBITDA
$371B 4.1x 11.5x
$329B 0.8x 8.6x
$231B 5.4x 20.7x
$223B 2.5x 14.2x
$163B 9.2x 30.7x
$162B 6.9x 24.9x
$155B 6.4x 20.4x
$128B 3.8x 13.2x
$32.9B 7.7x 27.4x
$29.7B 1.5x 9.6x
$27.1B 2.0x 12.0x
$26.5B 6.8x 21.2x
$25.0B 6.0x 18.7x
$18.8B 4.7x 15.4x
$11.3B 9.0x 61.8x
$11.3B 0.3x 5.7x
$11.2B 7.3x 27.8x
$10.4B 3.0x 11.7x
$7.4B 9.7x 36.6x
$6.3B 2.6x 14.9x
$5.7B n/a n/a
$4.9B 1.5x 8.0x
$4.5B 5.2x 21.6x
$4.2B 4.7x 24.5x
$3.8B 1.4x 9.1x
$3.6B 1.4x 11.5x
$2.4B 2.6x 13.2x
$2.4B 0.2x 8.9x
$2.2B 3.8x -15.1x
$1.5B 3.4x 29.8x
$1.3B 0.3x 3.5x
$1.3B 17.4x 33.6x
$1.0B 1.1x 27.4x
$923M 2.3x 12.0x
$912M n/a n/a
$867M 7.1x 56.8x
$755M n/a n/a
$697M 2.0x 23.8x
$583M 1.2x 4.5x
$570M n/a n/a
$476M 3.3x 7.5x
$464M 10.0x -16.9x
$456M 133.6x -13.1x
$367M 13.4x n/a
$366M 1.5x 5.0x
$336M 158.9x -21.9x
$308M 0.7x 11.1x
$296M n/a n/a
$263M 622.0x -6.2x
$247M 0.9x 2.7x
$242M 0.8x 4.9x
$228M 0.4x 2.8x
$179M 2.9x 13.6x
$159M n/a n/a
$152M 1.1x 5.8x
$133M n/a n/a
$128M 0.6x 6.6x
$112M 0.9x 32.5x
$110M 951.3x n/a
$110M 2.3x 9.4x
$103M 38.1x -1.3x
$103M 1.8x -4.2x
$102M 2.6x -22.0x
$94.1M 12.7x n/a
$93.2M 1.9x 48.5x
$89.5M 1.7x -1.9x
$80.5M 3.6x -17.9x
$80.5M n/a n/a
$80.3M 0.7x 3.2x
$79.1M n/a n/a
$78.1M 17.7x -3.9x
$71.7M 2.8x 50.0x
$59.0M n/a n/a
$52.5M 4.5x n/a
$52.1M n/a n/a
$48.5M 2.6x -1056.8x
$45.3M n/a n/a
$42.5M 0.7x -30.7x
$42.5M n/a n/a
$42.1M 1.9x -38.7x
$36.3M n/a n/a
$33.5M 3.5x -3.9x
$31.7M 1.1x -1.1x
$28.5M 4.1x -3.7x
$27.1M n/a n/a
$26.7M 0.5x -63.9x
$18.1M n/a n/a
$17.7M n/a n/a
$15.2M n/a n/a
$10.6M n/a n/a
-$2.3M n/a n/a
-$15.4M -5.8x n/a
-$34.0M -27.3x 0.4x

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.